Abstract: Preserved ratio impaired spirometry (PRISm) is a pulmonary function pattern characterized by a forced expiratory volume in one second (FEV1) to forced vital capacity ratio greater than 0.70, ...

Spirometry test There is significant disparity in the ratios for postbronchodilator FEV1/FEV6 and FEV1/FVC %, and this disparity is very pronounced in women. Disclosure: One study author declared ...

A recent study published in the journal of Radiology showed that dynamic chest radiography (DCR) may serve as an effective ...

The guideline-recommended FEV1:FVC value of less than 0.70 is the optimal cutoff for the diagnosis of clinically significant chronic obstructive pulmonary disease (COPD), researchers say. The study, ...

Please provide your email address to receive an email when new articles are posted on . Preserved ratio impaired spirometry is a common lung function trait associated with breathlessness, ...

Bronchiolitis obliterans syndrome (BOS) is a serious complication of chronic GVHD (cGVHD) following HSCT (hematopoietic SCT). The clinical diagnosis of BOS is based on pulmonary function test (PFT) ...

Good technique is essential when undertaking spirometry tests, and correct interpretation of the results is important to avoid making an incorrect diagnosis. Lung function results are reported as ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Patients with preserved ratio impaired spirometry (PRISm ...

Spirometry is a standard test doctors use to determine how well your lungs function. A score that measures airflow into and out of your lungs can help diagnose COPD and determine the best treatments.

Better lung function, expressed as higher forced vital capacity (FVC), is associated with a reduced risk for the onset of heart disease, diabetes, and stroke over a follow-up period of approximately ...

After 12 weeks of nebulized NAC, patients’ mean phlegm scores, as measured by the COPD assessment test, significantly decreased from 3.47 at baseline to 2.62. N-acetylcysteine (NAC) nebulizer therapy ...